Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment [Phase 2]
Phase 2 clinical trial update for AP1189 in DMARD-naïve rheumatoid arthritis patients completed.
-
FDA approval · 2023-11-03FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approves a supplemental application for HUMIRA (adalimumab) to Cordavis Limited, enabling an additional manufacturing/supply pathway for…
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis [Phase 1]
Phase 1 safety and tolerability trial of PF-06835375 in seropositive systemic lupus erythematosus and rheumatoid arthritis completed; result…
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate [Phase 3]
Phase 3 trial evaluating GSK3196165 vs placebo and tofacitinib in adults with moderately to severely active rheumatoid arthritis unresponsiv…
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis [Phase 2]
Phase 2 study update for LNK01001 capsule in moderately to severely active rheumatoid arthritis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-10-20FDA Approved: COXANTO — Original Application (SOLA Pharmaceuticals, LLC)
The FDA approved COXANTO (oxaprozin) from SOLA Pharmaceuticals in its original application, enabling its use for pain and inflammation assoc…
-
FDA approval · 2023-10-20FDA Approved: ZYMFENTRA — Original Application (CELLTRION USA Inc.)
FDA approved ZYMFENTRA (inflximab-dyyb) from Celltrion USA as a biosimilar to infliximab (Remicade), based on demonstration of biosimilarity…
-
FDA approval · 2023-10-18FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Zimmer POLAR - Total Knee Arthroplasty (TKA) [NA]
Clinical trial update for Zimmer POLAR total knee arthroplasty (TKA) with completed status and results posted.
-
FDA approval · 2023-10-11FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approved Naproxen and Esomeprazole Magnesium (ScieGen Pharmaceuticals) under Original Application. The combination is indicated for reli…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis [NA]
Clinical trial update for Ascension post-approval study reporting termination with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone [Phase 3]
Phase 3 trial comparing minocycline plus methotrexate versus methotrexate alone for early rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis
A completed clinical trial describing treatment patterns and effects of tofacitinib in patients with rheumatoid arthritis; results posted in…
-
FDA approval · 2023-09-21FDA Approved: ADALIMUMAB — Supplemental Application (CELLTRION USA, Inc.)
FDA approved a supplemental Biologics License Application for the adalimumab biosimilar ADALIMUMAB-AATY from Celltrion USA, approving its bi…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis [Phase 3]
Phase III trial completed evaluating a recombinant anti-IL-6 receptor monoclonal antibody added to methotrexate for moderate to severe rheum…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients [Phase 3]
Phase 3 clinical trial comparing Rebamipide (regular and nanoparticulated forms) to Clobetasol for methotrexate-induced oral ulceration in r…
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Anterior Advantage With KINCISE [NA]
A clinical trial update for the KINCISE program was terminated; results have been posted previously.
-
FDA approval · 2023-09-14FDA Approved: SOVUNA — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SOVUNA (hydroxychloroquine sulfate) submitted by ANI Pharmaceuticals, under NDA 214581.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders [Phase 4]
A Phase 4 trial comparing abatacept versus tocilizumab for rheumatoid arthritis in patients who inadequate respond to TNF inhibitors is ongo…
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood [NA]
A completed clinical trial investigating acupuncture for rheumatoid arthritis with monitoring of the microbiome and blood biomarkers; result…
-
FDA approval · 2023-09-07FDA Approved: INDOMETHACIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Indomethacin submitted by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: ACTH Gel Therapy in Rheumatoid Arthritis [NA]
A completed clinical trial evaluating ACTH gel therapy for rheumatoid arthritis with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial update on TLL-018 for rheumatoid arthritis reports safety and efficacy data; study completed.
-
FDA approval · 2023-08-31FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
The FDA approved a supplemental application for tolmetin sodium from Atland Pharmaceuticals, LLC. This action approves changes under an appr…
-
FDA approval · 2023-08-24FDA Approved: SULFASALAZINE — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for the generic drug sulfasalazine submitted by Chartwell RX, LLC.